文献速递精神分裂症与精神病性障碍

围青春期长期大麻素暴露对啮齿类动物精神分裂症样行为影响的系统综述与荟萃分析

Systematic review and meta-analysis on the effects of chronic peri-adolescent cannabinoid exposure on schizophrenia-like behaviour in rodents.
PubMed 文献 · Mol Psychiatry · 2024-08-02

该系统综述与荟萃分析纳入108篇文章的359项实验,评估围青春期重复大麻素暴露后啮齿类动物精神分裂症样行为的变化。CB1R激动剂(天然与合成)广泛诱发工作记忆、新物体识别、新物体位置识别、社交新奇偏好、社交动机、前脉冲抑制和蔗糖偏好损害,而新异性诱导运动效应可忽略;CBD可能增强恐惧记忆回忆但数据有限。

要点

  • CB1R激动剂诱发广泛精神分裂症样行为损害,包括工作记忆和社交动机等。
  • 新异性诱导运动效应可忽略,性别和物种亚组效应相似。
  • CBD可能增强恐惧记忆回忆,但数据有限。

核心结论

  • 本荟萃分析支持早期大麻使用与精神分裂症样表型之间的流行病学联系,并确认动物模型的效用。
  • 标准化实验方案将优化模型以增强可重复性和比较,本研究为完善啮齿类模型以阐明大麻与精神分裂症之间的生物学通路提供了框架。

研究设计与样本

  • 遵循预注册方案(CRD42022338761),检索PubMed、Ovid Medline、Embse和APA PsychInfo截至2024年5月的英文原创研究。
  • 纳入108篇文章的359项实验,涵盖9种行为测试,评估大鼠和小鼠在围青春期(P23-P45之间开始)重复大麻素暴露后的精神分裂症样行为。
  • 使用SYRCLE工具评估偏倚风险。

主要发现

  • CB1R激动剂(天然和合成)诱发工作记忆损害[g = -0.56;(CI:-0.93,-0.18)]。
  • CB1R激动剂诱发新物体识别损害[g = -0.66;(CI:-0.97,-0.35)]和新物体位置识别损害[g = -0.70;(CI:-1.07,-0.33)]。
  • CB1R激动剂诱发社交新奇偏好损害[g = -0.52;(CI:-0.93,-0.11)]和社交动机损害[g = -0.21;(CI:-0.42,-0.00)]。
  • CB1R激动剂诱发前脉冲抑制损害[g = -0.43;(CI:-0.76,-0.10)]和蔗糖偏好损害[g = -0.87;(CI:-1.46,-0.27)]。
  • 新异性诱导运动效应可忽略;亚组分析显示性别和物种间效应相似;观察到实验方案存在大量变异,行为结局存在中高度异质性;CBD可能增强恐惧记忆回忆,但数据有限。

局限性

  • 观察到实验方案存在大量变异,行为结局存在中高度异质性。
  • CBD可能增强恐惧记忆回忆,但数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The link between cannabis use and schizophrenia is well-established in epidemiological studies, especially among adolescents with early-onset use. However, this association in rodent models is less clear. This meta-analysis examined the effects of adolescent cannabinoid exposure on distinct schizophrenia-like behaviours in rodents and how experimental variations influence outcomes. METHODS: Following a pre-registered protocol (CRD42022338761), we searched PubMed, Ovid Medline, Embse and APA PsychInfo for English-language original studies until May 2024. We synthesised data from experiments on schizophrenia-like behaviour in rats and mice after repeated peri-pubertal (onset between P23-P45) cannabinoid exposure. Risk of bias was assessed using the SYRCLE's tool. RESULTS: We included 359 experiments from 108 articles across 9 behavioural tests. We found meta-analytic evidence supporting that CB1R agonists, both natural and synthetic, elicited broad schizophrenia-like behavioural alterations, including impaired working memory [g = -0.56; (CI: -0.93, -0.18)], novel object recognition [g = -0.66; (CI: -0.97, -0.35)], novel object location recognition [g = -0.70; (CI: -1.07, -0.33]), social novelty preference [g = -0.52; (CI: -0.93, -0.11)], social motivation [g = -0.21; (CI: -0.42, -0.00)], pre-pulse inhibition [g = -0.43; (CI: -0.76, -0.10)], and sucrose preference [g = -0.87; (CI: -1.46, -0.27)]. By contrast, effects on novelty-induced locomotion were negligible. Subgroup analyses revealed similar effects across sexes and species. Substantial variance in the protocols and moderate-to-high heterogeneity in behavioural outcomes were observed. We found CBD may enhance fear memory recall, but data was limited. DISCUSSION: This is the first meta-analysis to comprehensively assess the link between cannabinoids and schizophrenia-like behaviours in rodents. Our results support epidemiological links between early cannabis use and schizophrenia-like phenotypes, confirming the utility of animal models. Standardising protocols will optimise models to strengthen reproducibility and comparisons, our work provides a framework for refining rodent models to elucidate biological pathways linking cannabis and schizophrenia.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Li Z, Mukherjee D, Duric B, et al. Systematic review and meta-analysis on the effects of chronic peri-adolescent cannabinoid exposure on schizophrenia-like behaviour in rodents. Mol Psychiatry. 2024. PMID: 39090371. doi:10.1038/s41380-024-02668-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。